SCHEMBL4489409

SCHEMBL4489409

CCCN(CCC)C(=O)c1ccc(O)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 2/20 0.64
EGFR P00533 2/20 0.60
ERBB2 P04626 2/20 0.60
TP53 P04637 1/20 0.55
HPGD P15428 3/20 0.53
BACE1 P56817 1/20 0.52
HSD17B3 P37058 5/20 0.52
ESR1 P03372 2/20 0.51
ESR2 Q92731 1/20 0.51
GABRA1 P14867 1/20 0.51
GABRB2 P47870 1/20 0.51
HDAC1 Q13547 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
ALDH1A1 P00352 2/20 0.47
CHRM1 P11229 1/20 0.47
TSHR P16473 1/20 0.47
SLC6A2 P23975 1/20 0.47
KDR P35968 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
ESRRG P62508 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9694832 0.92 MLYCD (0.72) MLYCDEGFRERBB2TP53HPGD
SCHEMBL5968307 0.89 EGFR (0.62) MLYCDEGFRERBB2HPGDHSD17B3
SCHEMBL21708320 0.85 HSD17B3 (0.57) MLYCDEGFRERBB2TP53HPGD
SCHEMBL7967022 0.84 MLYCD (0.64) MLYCDEGFRERBB2TP53HPGD
SCHEMBL26313600 0.84 MLYCD (0.64) MLYCDEGFRERBB2TP53HPGD
SCHEMBL26314066 0.84 MLYCD (0.64) MLYCDEGFRERBB2TP53HPGD
SCHEMBL1806308 0.83 HPGD (0.63) MLYCDHPGDALDH1A1TDP1
SCHEMBL16493827 0.83 OPRD1 (0.48) MLYCDEGFRERBB2TP53HPGD
SCHEMBL10777907 0.82 MLYCD (0.62) MLYCDEGFRERBB2TP53HPGD
SCHEMBL5543209 0.82 MLYCD (0.62) MLYCDEGFRERBB2TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101230033-B New azabicycloalkane derivatives, preparing method and medicament combination containing the same SERVIER LAB 2011-03-09 CN disclosed
CN-100577160-C Novel azabicyclo derivatives, preparation method thereof and pharmaceutical compositions containing same SERVIER LAB 2010-01-06 CN disclosed
US-7576120-B2 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2009-08-18 US disclosed
CN-101230033-A New azabicycloalkane derivatives, preparing method and medicament combination containing the same SERVIER LAB (FR) 2008-07-30 CN disclosed
EP-1720544-B1 NOVEL AZABICYCLIC DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SERVIER LAB (FR) 2008-03-19 EP disclosed
US-20070197625-A1 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them. LES LABORATORATIES SERVIER (FR) 2007-08-23 US disclosed
CN-1921848-A Novel azabicyclo derivatives, preparation method thereof and pharmaceutical compositions containing same SERVIER LAB (FR) 2007-02-28 CN disclosed
EP-1720544-A1 NOVEL AZABICYCLIC DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Les Laboratoires Servier (FR) 2006-11-15 EP disclosed
WO-2005089747-A1 NOVEL AZABICYCLIC DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2005-09-29 WO disclosed
WO-1997027173-A2 DIHALOPROPENE COMPOUNDS, THEIR USE AS INSECTICIDES/ACARICIDES AND INTERMEDIATES FOR THEIR PRODUCTION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1997-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197625-A1 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them. HRH2, HNMT, HRH1 MLYCD 3761/4885EGFR 1139/4885ERBB2 451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.